Equine Research Funding

Equine Research Funding

View the recommendations from the Equine Research Committee that were recently approved by the American Quarter Horse Foundation Board of Trustees.

horses at sunset generic (Credit: Sarah Anderson)

text size

The American Quarter Horse Foundation Board of Trustees recently reviewed and approved grant funding for projects recommended by the Equine Research Committee. These research projects were approved by the AQHA membership and the Board of Directors at the 2022 AQHA Convention and by the AQHA Executive Committee following the convention.

The Board of Trustees approved funding of $264,488.20 from the Foundation’s general research fund for the following projects:

  • “Characterizing Nasal T Cell Populations in Equine Herpesvirus Type 1 (EHV-1) Immune and Susceptible Horses” at Cornell University

  • “An EHV-1 mRNA-based Vaccine Delivered in Extracellular Vesicles” at Iowa State University

  • “Bile Acid Profiling of Pyloric Gastric Fluid and Serum in Horses with and without Equine Glandular Gastric Disease” at Louisiana State University

  • “Stress-induced Clodronate Release to Peak Exercise Training or Bone Insult following Repetitive Administration in Young Horses” at Montana State University

  • “Response of Healthy Joints to Intra-Articular Corticosteroids in Young, Exercising Horses” at Texas A&M University

Also approved is grant funding from the Foundation’s Refrigerator Fund for Equine Head Trauma in the amount of $40,835 for “Three-dimensional Finite Element Simulations of Equine Traumatic Brain Injury following Trauma” at the University of Florida.

2023-24 Areas of Research Funding Interest
The Foundation supports research to improve knowledge for public benefit to advance the health, welfare and utility of the American Quarter Horse. The Equine Research Committee will consider all proposals meeting this overarching goal, with special attention to the following areas of interest for the 2023-24 grant cycle:

  • Equine welfare: discovery and detection of performance enhancing drugs, masking agents, fitness parameters for competition, exercise physiology, training and factors of aging.

  • Genomics: detection of variants contributing to genetic disorders, detection of offspring from cloned animals, behavior, obesity, selective breeding practices and testing.

  • Infectious diseases: vaccination and testing for CEM, EHM, EIA and EVA.

  • Microbiome of the horse: metabolism, links to the immune system, management and feeds.

  • Nutrition: nutritional management, EMS and related diseases, supplements.

The full standing committee reports are available at www.aqha.com/committee-reports. View highlights from the additional standing committee reports.

AQHA News and information is a service of the American Quarter Horse Association. For more news and information, follow @AQHA on Twitter and visit www.aqha.com/news.